$Bristol-Myers Squibb(BMY)$ @T

BMY

11-10 22:30

USBristol-Myers Squibb

Side	Price \| Filled	Realized P&L
Sell Close	47.00 400	+7.41% Closed

Bristol-Myers Squibb

Trade Feed: Who is your favorite trader?

Come to the Trade Feed Topic to find more trading opportunities! Also, please feel free to recommend and introduce fellow Tigers to the "hidden gem traders" that you've discovered!

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

Trade Feed Decoder
11-11
Trade Feed Decoder
The BMY trade realizes a 7.41% gain, suggesting disciplined profit-taking in a pharmaceutical sector facing mixed fundamentals (BMY -2% YTD vs. XLV +4%). The exit at $47 aligns with recent resistance levels, possibly capitalizing on a technical bounce after Q1 earnings stability. Given BMY's 4.8% dividend yield, the seller might prioritize capital redeployment over income retention. The trade reflects a tactical approach in a sector where pipeline developments and patent cliffs create asymmetric opportunities. While timing appears opportunistic, the lack of disclosed position size limits risk/reward assessment. This highlights the importance of context in healthcare trades, where catalysts like FDA decisions or M&A speculation often drive short-term moves despite long-term valuation metrics.

Leave a comment

{"i18n":{"language":"en_US"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":498729207137104,"tweetId":"498729207137104","gmtCreate":1762785047693,"gmtModify":1762785049861,"author":{"id":3564014836032088,"idStr":"3564014836032088","authorId":3564014836032088,"authorIdStr":"3564014836032088","name":"惆怅人间客","avatar":"https://static.tigerbbs.com/0d3944b70ec12dc91edbbf339f306077","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":12,"crmLevelSwitch":0,"currentWearingBadge":{"badgeId":"1026c425416b44e0aac28c11a0848493-3","templateUuid":"1026c425416b44e0aac28c11a0848493","name":" Tiger Idol","description":"Join the tiger community for 1500 days","bigImgUrl":"https://static.tigerbbs.com/8b40ae7da5bf081a1c84df14bf9e6367","smallImgUrl":"https://static.tigerbbs.com/f160eceddd7c284a8e1136557615cfad","grayImgUrl":"https://static.tigerbbs.com/11792805c468334a9b31c39f95a41c6a","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.11.04","individualDisplayEnabled":0},"individualDisplayBadges":[],"fanSize":1,"starInvestorFlag":true,"fullDisclosureFlag":true,"starInvestorFollowerNum":1,"starInvestorOrderShareNum":17,"userFollowInvestorFlag":false,"orderNotificationFlag":false,"ror":145.15,"showRor":true,"winRationPercentage":70.588235,"tradeVolumeEst":0},"themes":[{"themeId":"4e1ab37448a24dd39b7882426fc6fd27","categoryId":"ab3d937a5fd848c08008411a9be702b5","name":"Trade Feed: Who is your favorite trader?","type":0,"rnLink":"https://laohu8.com/RN?name=RNTheme&page=/theme/detail&rndata={\"themeId\":4e1ab37448a24dd39b7882426fc6fd27}&rnconfig={\"headerBarHidden\": true}","description":"Come to the Trade Feed Topic to find more trading opportunities! Also, please feel free to recommend and introduce fellow Tigers to the \"hidden gem traders\" that you've discovered!","image":"https://community-static.tradeup.com/news/e496e574dd744490c7b4f7959f83f5a4"}],"images":[],"coverImages":[],"html":"<html><head></head><body><a href=\"https://ttm.financial/S/BMY\">$Bristol-Myers Squibb(BMY)$&nbsp;</a><a href=\"https://ttm.financial/U/10000000000011061\">@Trade Feed Decoder</a></body></html>","htmlText":"<html><head></head><body><a href=\"https://ttm.financial/S/BMY\">$Bristol-Myers Squibb(BMY)$&nbsp;</a><a href=\"https://ttm.financial/U/10000000000011061\">@Trade Feed Decoder</a></body></html>","text":"$Bristol-Myers Squibb(BMY)$ @Trade Feed Decoder","highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"favoriteSize":0,"link":"https://ttm.financial/post/498729207137104","repostId":0,"isVote":1,"tweetType":1,"viewCount":144,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["BMY"],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":true,"orderData":{"uuid":"3564014836032088","orderId":"41100466200382464","kind":"TRADE","symbol":"BMY","secType":"STK","symbolHtmlTag":"<a href=\"https://ttm.financial/S/BMY\">$Bristol-Myers Squibb(BMY)$&nbsp;</a>","symbolHtmlTagHref":"https://ttm.financial/S/BMY","symbolName":"Bristol-Myers Squibb","market":"US","action":"SELL","currency":"USD","symbolLogo":"","showFilledQuantity":true,"nameCN":"Bristol-Myers Squibb","orderType":"LMT","filledQuantityFinal":400,"avgFillPrice":47,"createTime":1762785025,"filledQuantity":"400","filledQuantityScale":"0","openFlag":false,"side":"DEBIT","contractMajorDescription":"Bristol-Myers Squibb","contractExtraDescription":"BMY","legs":[],"completedFlag":true,"orderPnl":{"realizedPnlPercent":0.0741,"realizedPnlByAveragePercent":0.0741},"quickOrderFlag":false},"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":["订单分享帖","未分享订单分享帖"],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":17,"optionInvolvedFlag":false,"xxTargetLangEnum":"ORIG"},"commentList":[{"id":498758667886656,"commentId":"498758667886656","gmtCreate":1762792231942,"gmtModify":1762793334025,"authorId":10000000000011060,"author":{"id":10000000000011060,"idStr":"10000000000011061","authorId":10000000000011060,"name":"Trade Feed Decoder","avatar":"https://community-static.tradeup.com/news/4dc8fec78bad5acffbf563bdbc6bc8ed","vip":4,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":498729207137104,"objectIdStr":"498729207137104","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"The BMY trade realizes a 7.41% gain, suggesting disciplined profit-taking in a pharmaceutical sector facing mixed fundamentals (BMY -2% YTD vs. XLV +4%). The exit at $47 aligns with recent resistance levels, possibly capitalizing on a technical bounce after Q1 earnings stability. Given BMY's 4.8% dividend yield, the seller might prioritize capital redeployment over income retention. The trade reflects a tactical approach in a sector where pipeline developments and patent cliffs create asymmetric opportunities. While timing appears opportunistic, the lack of disclosed position size limits risk/reward assessment. This highlights the importance of context in healthcare trades, where catalysts like FDA decisions or M&amp;A speculation often drive short-term moves despite long-term valuation metrics.","text":"The BMY trade realizes a 7.41% gain, suggesting disciplined profit-taking in a pharmaceutical sector facing mixed fundamentals (BMY -2% YTD vs. XLV +4%). The exit at $47 aligns with recent resistance levels, possibly capitalizing on a technical bounce after Q1 earnings stability. Given BMY's 4.8% dividend yield, the seller might prioritize capital redeployment over income retention. The trade reflects a tactical approach in a sector where pipeline developments and patent cliffs create asymmetric opportunities. While timing appears opportunistic, the lack of disclosed position size limits risk/reward assessment. This highlights the importance of context in healthcare trades, where catalysts like FDA decisions or M&amp;A speculation often drive short-term moves despite long-term valuation metrics.","html":"The BMY trade realizes a 7.41% gain, suggesting disciplined profit-taking in a pharmaceutical sector facing mixed fundamentals (BMY -2% YTD vs. XLV +4%). The exit at $47 aligns with recent resistance levels, possibly capitalizing on a technical bounce after Q1 earnings stability. Given BMY's 4.8% dividend yield, the seller might prioritize capital redeployment over income retention. The trade reflects a tactical approach in a sector where pipeline developments and patent cliffs create asymmetric opportunities. While timing appears opportunistic, the lack of disclosed position size limits risk/reward assessment. This highlights the importance of context in healthcare trades, where catalysts like FDA decisions or M&amp;A speculation often drive short-term moves despite long-term valuation metrics.","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"hot","coins":0,"score":0,"disclaimerFlag":true,"disclaimerType":1,"specialCommentTag":"AI_ANALYSE"}],"isCommentEnd":false,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/498729207137104"}